Predict potential heart failure events weeks in advance¹

Introducing HeartLogicTM

HeartLogic is Boston Scientific's innovative diagnostic tool designed to revolutionize heart failure management. Embedded in select implantable cardiac devices, HeartLogic utilizes a sophisticated multi-sensor algorithm to monitor vital physiological parameters, including heart sounds, respiration rate, thoracic impedance, heart rate, and physical activity.

This powerful technology calculates a HeartLogic Index to detect early signs of heart failure, providing clinicians with critical alerts before symptoms escalate. With HeartLogic, healthcare professionals can intervene earlier, enhancing patient care and outcomes in heart failure management. 

The Impact of Heart Failure on Quality of Life and Healthcare Economics

How HeartLogic Works

Our Multiple Sensors. Your Sixth Sense.

The HeartLogic Heart Failure Diagnostic uses multiple sensors to track physiological trends, combines them into one composite index and sends a proactive alert of potential worsening heart failure¹.

Discover the Multi-Sensor Advantage
NICE HeartLogic

NICE recommends HeartLogic

NICE founds HeartLogic to be the most accurate and consistent among reviewed heart failure algorithms in the UK market⁶.

 

See the Data

Stay Up to Date

Sign up here to receive emails about major conferences, clinical studies and technology updates.

Sign up today

Featured Clinical Data

Results From the MultiSENSE Study

HeartLogic Multisensor Algorithm Identifies Patients During Periods of Increased Risk of Heart Failure Events

Read the Article

Heart Failure and Sudden Cardiac Death products

Your extraordinary talent. Our extraordinary technology. Explore the Boston scientific CRT-Ds and ICDs that feature HeartLogic.

Explore Products

LATITUDE NXT™ Remote Patient Management System: Indications, Safety and Warnings

Resonate™ ICD: Indications, Safety and Warnings

Resonate™ CRT-D: Indications, Safety and Warnings

References
1. Boehmer JP, Hariharan R, Devecchi FG, et al. A Multisensor algorithm predicts heart failure events in patients with implanted devices: results from the MultiSENSE study. JACC Heart Fail. 2017 Mar;5(3):216-25.
2. After Hospitalization: A Dartmouth Atlas Report on Post-Acute Care for Medicare Beneficiaries, Sept28th, 2011.
3. Fonarow GC, Abraham WT, Albert NM, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. J AMA. 2007;297(1):61–70. https://www.ncbi.nlm.nih.gov/pubmed/17200476.
4. O’Connor CM, Abraham WT, Albert NM, et al. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2008
5. https://circ.ahajournals.org/content/123/8/933?ijkey=ef69d682d9a0210be678bba2f4bd7f3bac3b1239&keytype2=f_ipsecsha
6. National Institute of Health and Care Excellence. NICE guidance DG72, Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices, Updated External Assessment Report (dated 20 March 2024), produced by Newcastle Technology Assessment Review Group, Newcastle University, published as part of committee papers, 14 May 2024.

CAUTION:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device. Information for use only in countries with applicable health authority registrations. Material not intended for use in France.
All cited trademarks are the property of their respective owners.